Campbell, Noll L.
Hines, Lisa
Epstein, Andrew J.
Walker, David
Lockefeer, Amy
Shiozawa, Aki http://orcid.org/0000-0001-9757-6337
Funding for this research was provided by:
astellas pharma global development
Article History
Accepted: 19 September 2021
First Online: 8 November 2021
Declarations
:
: This study was funded by Astellas Pharma Global Development.
: AS, DW, and AL are employees of Astellas and may own Astellas stock. NLC received consulting fees from Astellas Pharma for the conduct of this study. AJE (Medicus Economics) received funding from Astellas Pharma to develop, conduct, and analyze the study. LH is an employee of the Pharmacy Quality Alliance, the developer of the measure used in this research.
: Not applicable.
: Not applicable.
: Not applicable.
: Researchers may request access to anonymized participant level data, trial level data, and protocols from Astellas sponsored clinical trials at ExternalRef removed. For the Astellas criteria on data sharing, see ExternalRef removed. The data that support the findings of this study are available from the Centers for Medicare and Medicaid Services, but restrictions apply to the availability of these data, which were used under license for the current study, and thus are not publicly available. Data are however available from the authors upon reasonable request and with permission of the Centers for Medicare and Medicaid Services.
: Not applicable.
: All authors contributed to the study conception and design. Data analyses were performed by AJE. All authors contributed to the writing of the manuscript. All authors read and approved the final manuscript.